Hadasit Bio-Holdings - Press Releases http://www.hbl.co.il Enlivex has completed patient enrollment in its Phase I/II clinical trial Sun 15 Jan 2012 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=107 Thrombotech Completes Additional Financing Round of $1.4 million Tue 10 Jan 2012 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=106 Recommendation to terminate Verto's activity - not expected to affect company. Fri 27 Nov 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=105 4 portfolio companies have received government grants for over 10 M NIS in 2011 Sat 14 Nov 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=102 BioMarCare receives approval for use of 400 samples from the Hadassah Medical Center Mon 30 Oct 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=101 BioMarCare Ltd. receives initial approval for a grant from the BIRD Foundation Fri 6 Jul 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=100 HBL announces that Thrombotech has begun its Phase IIa clinical trial Tue 3 Jul 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=99 Hadasit Bio-Holdings Begins Trading in U.S. through Launch of ADR Fri 27 Jun 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=98 BNY Mellon Appointed as Depositary Bank by Hadasit Bio-Holdings, Ltd. Fri 20 Jun 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=97 HBL announces an ADS trading program in the United States (OTCBB:HADSY) Thu 19 Jun 2011 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=96